cysteine and Prostatic Neoplasms, Castration-Resistant

cysteine has been researched along with Prostatic Neoplasms, Castration-Resistant in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Arora, H; Dulce, RA; Firdaus, F; Hare, JM; Kuchakulla, M; Masterson, T; Punnen, S; Qureshi, R; Ramasamy, R; Rosete, OJ; Shah, K; Soni, Y; Van Booven, DJ	1
Asemota, S; Bocharova, V; He, Y; Hwang, DJ; Jain, AK; Johnson, DL; Miller, DD; Narayanan, R; Petricoin, EF; Pfeffer, LM; Ponnusamy, S; Thiyagarajan, T; Yin, Z; Young, KL; Zhou, W	1
Antonarakis, ES; Blackford, A; Carducci, MA; Cho, SY; Ciarallo, A; Dannals, RF; Eisenberger, MA; Holt, DP; Kantoff, PW; Macura, KJ; Mease, RC; Mena, E; Nadal, R; Pomper, MG; Ross, AE; Rowe, SP	1

Trials

1 trial(s) available for cysteine and Prostatic Neoplasms, Castration-Resistant

Article	Year
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:1 Topics: Aged; Aged, 80 and over; Antigens, Surface; Cysteine; Glutamate Carboxypeptidase II; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Tomography, X-Ray Computed	2016

Article

Year

Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:1

Topics: Aged; Aged, 80 and over; Antigens, Surface; Cysteine; Glutamate Carboxypeptidase II; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Tomography, X-Ray Computed

2016

Other Studies

2 other study(ies) available for cysteine and Prostatic Neoplasms, Castration-Resistant

Article	Year
S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer. Cell death & disease, 2022, 10-08, Volume: 13, Issue:10 Topics: Cysteine; Humans; Macrophage Colony-Stimulating Factor; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Prostatic Neoplasms, Castration-Resistant; Receptor, Macrophage Colony-Stimulating Factor; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; S-Nitrosoglutathione; Tumor Microenvironment	2022
Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 2023, 01-03, Volume: 120, Issue:1 Topics: Androgen Receptor Antagonists; Cell Line, Tumor; Cysteine; Humans; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen	2023

Article

Year

S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer.

Cell death & disease, 2022, 10-08, Volume: 13, Issue:10

Topics: Cysteine; Humans; Macrophage Colony-Stimulating Factor; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Prostatic Neoplasms, Castration-Resistant; Receptor, Macrophage Colony-Stimulating Factor; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; S-Nitrosoglutathione; Tumor Microenvironment

2022

Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer.

Proceedings of the National Academy of Sciences of the United States of America, 2023, 01-03, Volume: 120, Issue:1

Topics: Androgen Receptor Antagonists; Cell Line, Tumor; Cysteine; Humans; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen

2023